Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$7.60 USD
-0.35 (-4.40%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $7.50 -0.10 (-1.32%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Brokerage Reports
Foghorn Therapeutics Inc. [FHTX]
Reports for Purchase
Showing records 61 - 80 ( 81 total )
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Validating Collaboration Deal with Ideal Partner LLY
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Lily Collaboration Further Strengthens Foghorn?s Gene Control Platform
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Beating the BAF Out of Cancer; Initiating With a Buy and $25 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Q3 Financials; Early Data Ahead for FHD-286; Deep in Degradation
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Q2 Financials; Clinical Programs Enrolling; R&D Day Highlights
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Q1 Financials; IND clearance for FHD-609; R&D Day Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Q4 Financials; FHD-286 and FHD-609 Clinical Studies Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Company: Foghorn Therapeutics Inc.
Industry: Medical - Drugs
Q3 Financials; 2021 Is the Year of the Clinic - Reiterate OUTPERFORM and $24 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R